ArticleCurrent therapeutic research, clinical and experimental2004

Metabolic effects of fluvastatin extended release 80 mg and atorvastatin 20 mg in patients with type 2 diabetes mellitus and low serum high-density lipoprotein cholesterol levels: a 4-month, prospective, open-label, randomized, blinded-end point (probe) trial.

Maurizio Bevilacqua et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.